Stephen J Denelsky insider trades

Open-market stock purchases and sales by Stephen J Denelsky, Director at Harvard Bioscience Inc, from SEC Form 4 filings since Sep 5, 2025.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +27%.

Recent trades

DateStockTradeValue
Jun 9, 2026HBIO Harvard Bioscience IncBought (not open market)—
Mar 17, 2026HBIO Harvard Bioscience IncBought$48.7K

Companies traded

  • HBIO Harvard Bioscience Inc: 1 buy, last Jun 9, 2026

Get free alerts when Stephen J Denelsky files a new trade →